Exhibit 99.1


August 19, 2008



Randy Moseley
Chairman, Board of Directors
CytoGenix, Inc.
3100 Wilcrest Drive, Ste. 140
Houston, TX 77042


Dear Mr. Moseley:

Please accept my  congratulations on your election as Chairman of the CytoGenix,
Inc. Board of Directors and your appointment as Chief Executive Officer.

I offer this statement to assist you in complying with the Company's requirement
to  file a Form  8-K  disclosure  under  the  Securities  Exchange  Act of  1934
regarding my resignation as CytoGenix, Inc. President/CEO and as a member of the
CytoGenix  Board  of  Directors.  I  wish  to  state  for  the  record  that  my
resignations  as Board member and Officer were submitted to enable the execution
of an Agreement to provide a bridge loan made by a group of investors to finance
the  Company  and to enable it to continue  operating.  As you know,  one of the
conditions precedent in the Bridge Loan Agreement,  Article 4.2(h),  required my
resignation from both positions.

I believe the Company's  technology  has great  promise and  concluded  that the
financing  offered by the investor  group was critical to preserve the Company's
ability to advance.  As you go forward, if I can be of any assistance to you and
the Company, please call upon me.

Very truly yours,


Malcolm Skolnick